MedEquineThe Triple Crown of Equine Health
 







MedEquine
> Home > Clinical Studies > Embro Research Corporation Clinical Studies

MedEquine
Embro Research Corporation Clinical Studies
MedEquine

In July of 2004, Empire Pharmaceutical Inc. purchased all of the assets of Embro Research Corporation, which included the proprietary product MedEquine®. The patented formulation of MedEquine® consists of the following ingredients: stannous fluoride, glycerin, purified water, zinc gluconate, and xanthan gum.

Embro Reseach Corporation, in their clinical evaluation of MedEquine®, found this product to be extremely safe and highly effective in the treatment of the following conditions:

Bacterial and Fungal Skin Infections such as Rain Rot (Dermatophilosis) and Ringworm (Dermatophytosis).

Summer and Girth Itch (associated with Staphylococcal bacterial infections).

Papilla or Facial Warts (associated with papilloma virus).

Throught their entire time of MedEquine® ownership, no adverse or harmful effects using this product were observed or reported to the company.

MedEquine
Extracted from
Embro Research Corporation Clinical Studies
MedEquine

Ringworm

Rain Scald (Rot)



Rubbing (Bites)

Girth Galls


MedEquine

[ Previous - Gainesville Study ] [ Next - Woodbine Race Track Studies ]




[ top ]


| Home | About MedEquine® | Photographs | Clinical Studies | Testimonials | Published Articles | Distributors | Contact Us |


DISCLAIMER: This web site was created to inform and to educate individuals about MedEquine®, a patented formulation of Empire Pharmaceutical Inc. As MedEquine® has not as yet received regulatory drug approval, any information contained within this web site should not be interpreted or misconstrued as either a direct or an indirect drug claim.


MedEquine
web site design & hosting by TANGO Web Media   Copyright © 2010 Empire Pharmaceutical Inc. All Rights Reserved.